Intuitive Surgical, Inc. (NASDAQ:ISRG) Q3 2023 Earnings Conference Call October 19, 2023 4:30 PM ET
Company Participants
Brian King - Head of IR
Gary Guthart - CEO
Jamie Samath - CFO
Myriam Curet - Chief Medical Officer
Conference Call Participants
Robbie Marcus - JPMorgan
Travis Steed - Bank of America
Larry Biegelsen - Wells Fargo
Brandon Vazquez - William Blair
Matthew Miksic - Barclays
Jayson Bedford - Raymond James
Ryan Zimmerman - BTIG
Anthony Petrone - Mizuho Group
Michael Polark - Wolfe Research
Operator
Thank you, everyone, for standing by. Welcome to the Intuitive Surgical Q3 2023 Earnings Release. [Operator Instructions]
I will now turn the conference over to your host, Head of Investor Relations, Intuitive Surgical, Brian King. Please go ahead.
Brian King
Good afternoon, and welcome to Intuitive's third quarter earnings conference call. With me today, we have Gary Guthart, our CEO; Jamie Samath, our CFO; and Dr. Myriam Curet, our Chief Medical Officer.
Before we begin, I would like to inform you that comments mentioned on today's call may be deemed to contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in our Securities and Exchange Commission filings, including our most recent Form 10-K filed on February 10, 2023, and Form 10-Q filed on July 24, 2023. Our SEC filings can be found through our website or at the SEC's website. Investors are cautioned not to place undue reliance on such forward-looking statements.
Please note that this conference call will be available for audio replay on our website at intuitive.com on the Events section under our Investor Relations page. Today's press release and supplementary financial data tables have been posted to our website.
Today's format will consist of providing you with highlights of our third quarter results, as described in our press release announced earlier today, followed by a question-and-answer session. Gary will present the quarter's business and operational highlights, Jamie will provide a review of our financial results, Myriam will present clinical highlights, and I will discuss procedure details and provide our updated financial outlook for 2023. And finally, we will host a question-and-answer session.
With that, I will turn it over to Gary.
Gary Guthart
Thank you for joining us today.
In this third quarter, we saw a strong growth in procedures performed by our customers, solid new system placements and healthy growth in utilization amid market conditions that remain largely consistent with Q2.